Hosted by the GPH Department of Biostatistics
Day-to-Day activities and responsibilities of a statistician/biostatistician in Big Pharma, Biotech, or a contract research organization (CRO) are determined by how these organizations interpret & implement guidelines from the ICH and fulfill requirements specified in the eCTD. These in turn set parameters of drug development: what a statistician does, when they fulfill requirements and execute guidelines, how they do it, and why it is necessary. Peek behind the curtain with Dr. Kevin Roberts, Director of Biostatistics at Pfizer, to see why the pharmaceutical industry is among the most regulated on earth.
About the Speaker:
Kevin Roberts, PhD is a Director of Biostatistics at Pfizer based in Cambridge. He joined Pfizer in 2019 and has over 15 years of experience working in the drug development space. His experience ranges from chemical, manufacturing and controls (CMC) through Medical affairs in multiple therapeutic areas. Dr. Roberts earned his PhD from Harvard University (2003) and was a post-doctoral fellow at Columbia University (2003-2005) prior to joining industry. Dr. Roberts was born in Trinidad & Tobago and emigrated to Brooklyn, NY when he was 3 years old.